SecBot SecBot
8-K ·Filed Jun 30, 2026

CELU

Celularity Inc
BEARISH
Impact 6/10
Horizondays Processed3mo ago SEC0001493152-26-031216
8-K material event: Items 1.01
Actionable Insight ▼ Bearish

The 30-day maturity and requirement to repay from a 'subsequent transaction' means Celularity must secure alternative financing or an equity/debt raise within weeks. Monitor for any 8-K announcing a subsequent transaction (equity offering, asset sale, or new debt) to repay this loan. Failure to do so could trigger default and enforcement of the security interest, potentially leading to a going-concern risk. The director resignation and recent management changes add uncertainty.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
CELU ▲ +92.34% at T+60d
SHORT call ✗ call lost -92.34% · α vs SPY -88.78% · entry $0.5979 → $1.15
Entry = T+0 close
Jun 30, 2026
via day close
T+1d
+1.07%
call -1.07% · α -1.21%
$0.6043
settled 4mo ago
T+5d
+33.80%
call -33.80% · α -33.20%
$0.8000
settled 4mo ago
T+20d
+25.61%
call -25.61% · α -26.63%
$0.7510
settled 3mo ago
T+60d
+92.34%
call -92.34% · α -88.78%
$1.15
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Celularity entered into a $1M secured loan agreement with a 5%+ shareholder (Philip Barach Family Trust) bearing 4% interest, maturing in 30 days or upon receipt of gross proceeds from a subsequent transaction. The loan is secured by substantially all personal property and required CEO Robert Hariri to subordinate his own debt. Separately, director Vincent LeVien resigned effective June 26, 2026, with no stated disagreement. Combined with recent C-suite appointments (COO and Chief Legal & Strategy Officer) just days prior, this filing signals acute near-term liquidity pressure and potential financial distress.

Key Financial Metrics

Deal Value
$1.0M
Deal Type
credit_facility

Key Facts

  • Celularity borrowed $1,000,000 from Philip & Daniele Barach Family Trust (a >5% shareholder) under a secured loan agreement dated June 29, 2026.
  • Loan bears 4.0% interest (18.0% upon default), matures the earlier of 30 days or receipt of gross proceeds from a subsequent transaction.
  • Loan is secured by a first-priority security interest in substantially all of Celularity's personal property, subject to excluded assets and existing liens.
  • As a condition to funding, CEO Robert J. Hariri entered into a waiver and subordination agreement regarding indebtedness owed to him by the company.
  • Director Vincent LeVien resigned effective June 26, 2026, with the company stating his resignation was not due to any disagreement.
  • This filing follows a June 19, 2026 8-K appointing Steven Gordon as COO and K. Harold Fletcher as Chief Legal & Strategy Officer.

Financial Impact

$1,000,000 secured loan at 4% interest, 30-day maturity, representing ~5.6% of the company's $18M market cap. The loan is a related-party transaction and signals urgent cash needs.

debtliquiditycash runway

Risk Factors

  • Default risk if the company cannot secure a subsequent transaction within 30 days to repay the loan.
  • Potential equity dilution if the subsequent transaction involves a dilutive offering.
  • Further management or board departures indicating deeper operational issues.
  • Enforcement of security interest on substantially all assets in event of default.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-031216
Document: form8-k.htm0001493152-26-031216
Document: 0001493152-26-031216-index-headers.html0001493152-26-031216
Document: 0001493152-26-031216-index.html0001493152-26-031216
Document: 0001493152-26-031216.txt0001493152-26-031216
15 reports for CELU
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CELU — sortable, filterable
TypeNow
Oct 20, 2026
6d ago
10-K/A
BEARISH ★ 5/10
$1.26awaiting T+60—$0.7500 (+40.48%)
Sep 30, 2026
26d ago
Press Release
NEUTRAL ★ 4/10
$1.35awaiting T+60—$0.7500 (−44.44%)
Sep 29, 2026
27d ago
8-K
NEUTRAL ★ 4/10
$1.35awaiting T+60—$0.7500 (−44.44%)
Sep 28, 2026
28d ago
SC 13D/A
BEARISH ★ 7/10
$1.40awaiting T+60—$0.7500 (+46.43%)
Sep 28, 2026
28d ago
8-K
BEARISH ★ 7/10
$1.40awaiting T+60—$0.7500 (+46.43%)
Sep 24, 2026
4w ago
Press Release
MIXED ★ 6/10
$1.32awaiting T+60—$0.7500 (−43.18%)
Sep 14, 2026
6w ago
8-K
MIXED ★ 5/10
$1.40awaiting T+60—$0.7500 (−46.43%)
Aug 25, 2026
8w ago
Press Release
BEARISH ★ 7/10
$0.8804awaiting T+60—$0.7500 (+14.81%)
Aug 7, 2026
11w ago
8-K
BEARISH ★ 5/10
$0.6866awaiting T+60—$0.7500 (−9.23%)
Jun 30, 2026
16w ago
8-K
BEARISH ★ 6/10
$0.5979 $1.15▼ −92.34%▼ −88.78%$0.7500 (−25.44%)
Showing 10 of 15

US Market Status

Market Closed — Opens in 8h 22m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 30, 2026